Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 796 $ 876
Restricted cash 1,032 860
Accounts and other receivables 283 218
Accounts receivable—related party 1 0
Inventory 150 160
Derivative assets 20 24
Other current assets 86 100
Total current assets 2,368 2,238
Non-current restricted cash 716 91
Property, plant and equipment, net 22,904 20,635
Debt issuance costs, net 197 277
Non-current derivative assets 43 83
Goodwill 77 77
Other non-current assets, net 295 302
Total assets 26,600 23,703
Current liabilities    
Accounts payable 62 49
Accrued liabilities 674 637
Current debt 0 247
Deferred revenue 65 73
Derivative liabilities 39 71
Total current liabilities 840 1,077
Long-term debt, net 24,654 21,688
Non-current deferred revenue 3 5
Non-current derivative liabilities 54 45
Other non-current liabilities 45 49
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at June 30, 2017 and December 31, 2016; Issued: 250.1 million shares at June 30, 2017 and December 31, 2016
Outstanding: 237.8 million shares and 238.0 million shares at June 30, 2017 and December 31, 2016, respectively 1 1
Treasury stock: 12.3 million shares and 12.2 million shares at June 30, 2017 and December 31, 2016, respectively, at cost (377) (374)
Additional paid-in-capital 3,228 3,211
Accumulated deficit (4,465) (4,234)
Total stockholders’ deficit (1,613) (1,396)
Non-controlling interest 2,617 2,235
Total equity 1,004 839
Total liabilities and equity $ 26,600 $ 23,703